What is the appropriate management for a 40-year-old patient with severe hypertension (BP 162/118), daily tetrahydrocannabinol (THC) use, ocular irritation from false eyelashes and dry eyes despite pataday 0.1% (olopatadine) eye drops, and recent bereavement?

Immediate Blood Pressure Management Required

This patient requires urgent initiation of antihypertensive medication with a two-drug combination therapy, specifically a RAS blocker (ACE inhibitor or ARB) combined with a calcium channel blocker, preferably as a single-pill combination, with a target BP of 120-129 mmHg. 1

Critical Blood Pressure Assessment

This BP of 162/118 mmHg represents Stage 2 hypertension but not a hypertensive emergency, as there is no evidence of acute target organ damage (no chest pain, headache, dyspnea, neurologic symptoms, or acute kidney injury mentioned) 2. The distinction is crucial:

• Hypertensive emergency requires BP >180/120 mmHg plus acute target organ damage and demands ICU admission 2
• This patient has severe hypertension requiring prompt outpatient treatment initiation, not emergent hospitalization 2

Pharmacological Management Algorithm

Start immediately with combination therapy:

1. First-line combination (choose one):

   • ACE inhibitor + amlodipine (dihydropyridine CCB), OR
   • ARB + amlodipine (dihydropyridine CCB)
   • Strongly prefer single-pill combination to improve adherence 1

2. Why combination therapy first? The 2024 ESC guidelines explicitly recommend combination therapy as initial treatment for confirmed hypertension ≥140/90 mmHg, as it provides more effective BP control than monotherapy 1

3. If BP remains uncontrolled after 2-4 weeks, escalate to three-drug combination: RAS blocker + CCB + thiazide/thiazide-like diuretic (chlorthalidone or indapamide preferred) 1

Target Blood Pressure

Target systolic BP: 120-129 mmHg (if well tolerated) 1. This aggressive target is supported by the most recent 2024 ESC guidelines to reduce cardiovascular risk.

Cannabis Use Considerations

Daily THC use does not contraindicate standard antihypertensive therapy. The evidence shows:

• Cannabis use (past or current, frequent or infrequent) is not associated with clinical hypertension 3
• THC acutely lowers BP through systemic hypotensive effects 4, but this is transient (3-4 hours) and does not interfere with chronic BP management
• No adjustment to standard antihypertensive protocols is needed for cannabis users

Ocular Management

The dry eye symptoms are likely multifactorial and require mechanical intervention:

1. Discontinue false eyelashes immediately - mechanical irritation from false lashes is the primary culprit for the "cold in the eyes" (likely mucoid discharge/crusting)

2. Continue Pataday 0.1% (olopatadine) - this is safe for dry eye patients 5. The FDA label confirms it does not worsen dry eye 6

3. Add artificial tears (preservative-free if using >4 times daily) for symptomatic relief

4. Important caveat: If wearing contact lenses, wait 10 minutes after Pataday instillation before insertion 6

Note on THC and ocular effects: Daily cannabis use can cause dry eyes and reduced corneal endothelial cell density 7, but this does not change the treatment approach. The ACE inhibitor or ARB chosen for BP management may actually improve dry eye symptoms, as ACE/ARB medications have been shown to increase tear film break-up time 8.

Dietary Modification

The daily bacon consumption requires immediate counseling:

• High sodium intake directly undermines BP control
• Recommend sodium restriction to <2 grams/day 1
• Increase potassium-rich foods (if no contraindication from kidney function)
• This is not optional - lifestyle modification is recommended alongside pharmacological therapy for all hypertensive patients 1

Bereavement Consideration

Recent loss of a relative may affect:

• Medication adherence - consider simplified regimen (single-pill combination)
• Follow-up reliability - schedule close follow-up (2-4 weeks) to assess BP response and provide support
• Stress-related BP elevation - while grief may transiently elevate BP, this reading still requires treatment

Follow-Up Protocol

1. Recheck BP in 2-4 weeks after initiating therapy
2. Assess for orthostatic hypotension at each visit (given cannabis use which can cause transient hypotension)
3. Baseline labs before starting: creatinine, electrolytes, glucose, lipid panel
4. Recheck labs 2-4 weeks after ACE/ARB initiation (monitor potassium and creatinine)
5. Titrate medications every 2-4 weeks until target BP achieved

Common Pitfalls to Avoid

• Do not delay treatment waiting for lifestyle modifications alone - this BP requires immediate pharmacological intervention 1
• Do not use beta-blockers as first-line unless there is a compelling indication (post-MI, heart failure, angina) - they are not recommended as initial therapy 1
• Do not treat this as hypertensive urgency requiring acute BP lowering in emergency department - this causes harm without benefit 2
• Do not attribute elevated BP solely to cannabis use - the evidence does not support this association 3